Drugs Made In Stock Performance

Drugs Made Relative Risk vs. Return Landscape

If you would invest  1,031  in Drugs Made In on November 6, 2025 and sell it today you would earn a total of  11.00  from holding Drugs Made In or generate 1.07% return on investment over 90 days. Drugs Made In is currently generating 0.0178% in daily expected returns and assumes 0.1128% risk (volatility on return distribution) over the 90 days horizon. In different words, 1% of stocks are less volatile than Drugs, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Drugs Made is expected to generate 4.7 times less return on investment than the market. But when comparing it to its historical volatility, the company is 6.66 times less risky than the market. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 of returns per unit of risk over similar time horizon.

Drugs Made Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Drugs Made has a beta of 0.0121 suggesting as returns on the market go up, Drugs Made average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Drugs Made In will be expected to be much smaller as well. Additionally Drugs Made In has an alpha of 0.0056, implying that it can generate a 0.005623 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Drugs Made

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Drugs Made In. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 10.31 10.42 10.53 Details

Intrinsic Valuation Low Real High 8.62 8.73 11.46 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Drugs Made. Your research has to be compared to or analyzed against Drugs Made's peers to derive any actionable benefits. When done correctly, Drugs Made's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Drugs Made In.

Drugs Made Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Drugs Made is not an exception. The market had few large corrections towards the Drugs Made's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Drugs Made In, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Drugs Made within the framework of very fundamental risk indicators.

Drugs Made Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Drugs Made for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Drugs Made In can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Drugs Made Price Density Drivers

Drugs Made Fundamentals Growth

When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.